NET PROFIT (x1000 DKK)
EMPLOYEES
Biocrine AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
![]() |
0 |
Financial expenses |
3
|
24
|
9 |
Earnings before taxes |
-6,584
|
-4,978
|
-6,175 |
EBITDA |
-6,625
|
-4,959
|
-5,116 |
Total assets |
8,930
|
14,102
|
9,913 |
Current assets |
287
|
6,364
|
2,165 |
Current liabilities |
2,438
|
1,092
|
520 |
Equity capital |
6,492
|
13,010
|
9,393 |
- share capital |
191
|
181
|
197 |
Employees (average) |
8
![]() |
8
![]() |
8 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
72.7%
|
92.3%
|
94.8% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) |
-73.7%
|
-35.1%
|
-62.2% |
Current ratio |
11.8%
|
582.8%
|
416.3% |
Return on equity (ROE) |
-101.4%
|
-38.3%
|
-65.7% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
0
![]() |
0
|
-1 |
Chg. No. of employees % |
0%
![]() |
0%
|
-11% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.